SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sandra who wrote (566)1/8/1998 6:21:00 PM
From: vestor  Read Replies (2) of 1837
 
I understand that there are 8 or 9 drugs in the FDA pipeline from DRMD. The recent FDA approval should generate about 5o million a year in revenues. The real block buster is the drug Cenestin which is the equal to Premarin. Premarin is the single most prescribed drug in the world I' told. I am not too familiar with the other drugs in the pipeline do you or anyone else know anything about them ? Also SURETRADEs weekly second opinion has upgraded the stock to a buy on 1/5. On the first of this series of FDA approvals the stock rose %110. P.S. Are you the same Sandra found on the ABTX thread ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News